New agents in the management of non-small-cell lung cancer

Cancer Control

Volumn 4, Issue 4, 1997, Pages 317-325

  Chiappori, A ^a   Devore, R F ^a   Johnson, D H ^a  

^a Division of Gynecologic Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; IRINOTECAN; NAVELBINE; PACLITAXEL; TOPOTECAN; VINDESINE;

ARTICLE; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; TREATMENT OUTCOME;

EID: 0030776238     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327489700400403     Document Type: Article

References (98)